Adage Capital Partners Gp, L.L.C. Gsk PLC Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $10.5 Million - $12.4 Million	-260,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $10.1 Million - $11.8 Million	260,000 New	260,000 $11.5 Million
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $15.4 Million - $17.1 Million	-425,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $6.18 Million - $7.33 Million	-175,000 Reduced 29.17%	425,000 $15.1 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $23.7 Million - $24.9 Million	600,000	600,000 $24.4 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.